Evgeniya Pushchina | Neuroscience | Best Researcher Award

Prof. Evgeniya Pushchina | Neuroscience | Best Researcher Award Ā šŸ†

Doctors of Science at National Scientific Centre of Marine BiologyšŸŽ“

Evgeniya Vladislavovna Pushchina is a distinguished specialist in cell biology, cytology, and histology. She holds the title of Doctor of Biological Sciences and is currently the Chief Researcher and Scientific Director of the Laboratory of Cell Differentiation at the National Scientific Center of Marine Biology, Far Eastern Branch of the Russian Academy of Sciences. She is also a Professor at the Russian Academy of Sciences. Her research focuses on neurochemistry, reparative neurogenesis, and postembryonic neurogenesis. šŸ§¬

 

Professional ProfileĀ 

Education šŸŽ“:

Evgeniya Vladislavovna earned her PhD in Biological Sciences, contributing extensively to the understanding of neurochemistry and cellular differentiation. She further advanced her expertise through continuous academic development, making significant contributions to biological research. šŸŽ“

Work Experience šŸ’¼:

Pushchina serves as the Chief Researcher and Scientific Director at the National Scientific Center of Marine Biology. Her leadership extends to various projects funded by grants from the President of the Russian Federation and the Russian Academy of Sciences. She is actively involved in scientific research and mentoring, contributing to the development of cutting-edge studies in neurobiology. šŸ’¼

Skills šŸ”

Evgeniya Vladislavovna is skilled in neurochemistry, cellular biology, and histology, particularly focusing on neurogenesis and brain morphogenesis. She is proficient in scientific writing, having published over 135 works, with 80 indexed in Scopus and WOS. Her research expertise extends to grant management and leading scientific collaborations. šŸ§ 

Awards and Honors šŸ†

Pushchina has been recognized for her outstanding scientific contributions. She is a recipient of grants from the President of the Russian Federation for young scientists, as well as for PhD and Doctor of Science projects. In 2024, she received the Jubilee Medal for the 300th Anniversary of Russian Science for her exceptional work in the field. šŸ…

šŸ¤ Memberships:

Evgeniya Vladislavovna is an active member of several scientific councils and committees, including the Academic Council of the NSCMB and the doctoral dissertation council D 005.008.01 at the IBM FEB RAS. She has been an expert of the Russian Academy of Sciences since 2016. Additionally, she serves on the editorial boards of several international scientific journals and acts as a reviewer for various prestigious publications. šŸŒ

Teaching Experience šŸ‘©ā€šŸ«:

She has a rich teaching background, having lectured at the Far Eastern Federal University and Kiev Medical University. Pushchina developed specialized courses on the evolutionary morphology of the nervous system and general histology. She also supervised numerous theses and dissertations, fostering the next generation of scientists. šŸ“š

Research Focus šŸ”¬:

Her research primarily centers on neurochemistry, particularly in the context of neurogenesis, both reparative and postembryonic. Pushchina’s work contributes to a deeper understanding of the central nervous system and its morphogenesis, with applications in marine biology and vertebrate neurobiology. šŸ”¬

ConclusionĀ 

Prof. Yi Zhang stands as an exemplary candidate for the Best Researcher Award due to his substantial contributions to the field of cellular immunotherapy and cancer research. His achievements align closely with the awardā€™s goals of recognizing innovation, impactful research, and contributions to society. With his strengths in pioneering therapy innovations and significant clinical applications, Prof. Zhangā€™s work exemplifies the awardā€™s spirit, making him a distinguished candidate for the Best Researcher Award.

šŸ“š Publilcation

 

Dr Alexander Chernov| neuro-oncology | Best Researcher Award

Dr Alexander Chernov| neuro-oncology | Best Researcher Award šŸ†


DR at Institute of Experimental MedicinešŸŽ“

Dr. Alexander Nikolaevich Chernov is a PhD and Senior Researcher at the World-Class Research Centre ā€œCenter for Personalized Medicineā€ at the Institute of Experimental Medicine, Saint Petersburg, Russia šŸ§¬. With an impressive portfolio of over 80 scientific papers, six patents, and ongoing collaborations with international institutions, Dr. Chernov has made significant contributions in the fields of neuroimmunooncology, glioblastoma research, and the study of nerve growth factors. In 2021, he defended his PhD thesis on the effects of nerve growth factor and immune peptides on brain tumor cells, and in 2022-2023, he completed a postdoctoral fellowship at Ben-Gurion University, Israel šŸ‡®šŸ‡±.

 

Professional ProfileĀ 

Education šŸŽ“

Dr. Chernov holds a PhD with expertise in neurobiology, focusing on brain tumors and chemotherapy. He has a solid foundation in biochemistry, serving as an assistant professor at Saint Petersburg State Pediatric Medical University šŸŽ“.

Work Experience šŸ¢

Dr. Chernovā€™s extensive research includes working as a senior researcher at multiple prestigious institutions in Russia, including the D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology. He has also been involved in numerous consultancy and industry projects across nine different sectors.

Awards and Honors šŸ†

Dr. Chernov has earned recognition for his exceptional work in brain tumor research, including the nomination for the Best Researcher Award for his article on glioblastoma sensitivity to antimicrobial peptides.

šŸ‘Øā€šŸ« Teaching & MembershipsšŸŒ

Dr. Chernov is a dedicated educator, currently teaching biochemistry at Saint Petersburg State Pediatric Medical University. He is a member of the Belarusian Society of Physiologists, contributing to his international scientific community .

Research Focus šŸ”

His main research areas include glioblastoma, nerve growth factors, chemotherapy, and antimicrobial peptides such as LL-37 and PG-1 šŸ§ . Dr. Chernovā€™s groundbreaking work has shown how these peptides, in combination with chemotherapy drugs, can predict overall survival in patients with glioblastoma. His research has also demonstrated the effects of these combinations on the inhibition of glioma cell clonogenicity and migration.

Publications :Ā 

 

  • “Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors”
    • Medicinal Chemistry, 2012
  • “Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier”
    • Pharmaceutics, 2011
  • “Biological activity of silver-doped DLC films”
    • Diamond and Related Materials, 2009
  • “Analysis of the Spectrum of ACE2 Variation Suggests a Possible Influence of Rare and Common Variants on Susceptibility to COVID-19 and Severity of Outcome”
    • Frontiers in Genetics, 2020
  • “Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients”
    • Frontiers in Immunology, 2021
  • “The phenomenon of multidrug resistance in glioblastomas”
    • Hematology/Oncology and Stem Cell Therapy, 2021
  • “Genetic risk factors for the development of COVID-19 coronavirus infection”
    • Russian Journal of Genetics, 2021
  • “Pharmacogenetic Study of the Impact of ABCB1 Single Nucleotide Polymorphisms on the Response to Cyclosporine in Psoriasis Patients”
    • Pharmaceutics, 2022
  • “Pathophysiological mechanisms of autism in children”
    • Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2020
  • “Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration”
    • Molecules, 2022